Solid Tumor-Induced Tolerogenic Dendritic Cell Immune Responses
01About This Special Issue
Potential topics include, but are not limited to:
- Immune tolerogenic dendritic cells in patients with non-small-cell lung cancer
- Dendritic cell-mediated immune responses in patients with prostate cancer
- Dendritic cell-mediated immune responses in patients with melanoma
- Dendritic cells and other typical solid tumors
02Meet the Guest Editors
Our distinguished editors bring deep subject-matter expertise to curate high-quality research and ensure a rigorous peer-review process.
Lead Guest Editor
Fang Zhou
Department of Tumor Immunology, Cas Lamvac Biomedical Co., Ltd., Guangzhou, China
Guest Editor
Hans Acha-Orbea
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
Guest Editor
Jonny Jonny
Cellular Centre, Gatot Soebroto Central Army Hospital, Jakarta, Indonesia
Guest Editor
James G Beeson
Department of Medicine, Burnet Institute, Melbourne, Australia
Guest Editor
Meredith O’Keeffe
Department of Biochemistry and Molecular Biology, University of Monash, Melbourne, Australia
Guest Editor
John R Gordon
Department of Medicine, University of Saskatchewan, Saskatoon, Canada
Guest Editor
Paula A Videira
Department of Molecular and Cellular Biology, New University of Lisbon, Lisbon, Portugal


